(Reuters) -Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S.

This brand-new Tundra TRD, riddled with cool accessories, will become yours thanks to the nonprofit organization A Race ...

The Washington Post News Service with Bloomberg budget for Sunday, Aug. 3, 2025. All stories have moved unless otherwise noted. The News Service hours of operation are as follows, with exceptions for ...

Three years ago, Daniel Cressy discovered his love of flying. But after hours of lessons, working toward his certification, ...

WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy.

Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment.

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy. The company's stock has been under pressure for weeks ...